Colesevelam hydrochloride
Sponsors
Daiichi Sankyo, Lars Kristian Munck
Conditions
Bile Acid MalabsorptionChronic DiarrheaHypercholesterolemiaType 2 DiabetesType 2 Diabetes Mellitus
Phase 2
Phase 3
WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes
CompletedNCT00147758
Start: 2004-06-30End: 2006-08-31Target: 400Updated: 2012-01-18
WelChol® With Metformin in Treating Patients With Type 2 Diabetes
CompletedNCT00147719
Start: 2004-06-30End: 2006-07-31Target: 300Updated: 2012-01-18
WelChol® and Insulin in Treating Patients With Type 2 Diabetes
CompletedNCT00151749
Start: 2004-06-30End: 2005-12-31Target: 260Updated: 2012-01-18
Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes
CompletedNCT00151762
Start: 2004-12-31End: 2007-07-31Target: 780Updated: 2008-01-09
Phase 4
Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol
CompletedNCT00185107
Start: 2005-03-31End: 2005-10-31Target: 45Updated: 2007-09-11
Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea
CompletedNCT03876717
Start: 2018-10-25End: 2022-02-13Updated: 2022-08-23